Manuel M. Garrido

Serum lipids and prostate cancer

Manuel M. Garrido, José C. Marta, Ruy M. Ribeiro et al. · Journal of Clinical Laboratory Analysis · 2021 · 25 citations · Full text

Medicine, Biostatistics, Oncology +17

The prostate health index (PHI) density: Are there advantages over PHI or over the prostate-specific antigen density?

Manuel M. Garrido, Ruy M. Ribeiro, Luís Campos Pinheiro et al. · Clinica Chimica Acta · 2021 · 21 citations · Full text

Medicine, Pathology, Urology +14

Tumour markers in prostate cancer: The post-prostate-specific antigen era

Manuel M. Garrido, Rui Bernardino, José C. Marta et al. · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · 2021 · 16 citations · Full text

Medicine, Oncology, Urology +17

Efficacy and safety of chemotherapy in older versus non-older patients with advanced gastric cancer: A real-world data, non-inferiority analysis

Laura Visa, Paula Jiménez‐Fonseca, Elena Asensio et al. · Journal of Geriatric Oncology · 2017 · 14 citations

Medicine, Geriatric Medicine, Oncology +16

The Percentage of [−2]Pro–Prostate-Specific Antigen and the Prostate Health Index Outperform Prostate-Specific Antigen and the Percentage of Free Prostate-Specific Antigen in the Detection of Clinically Significant Prostate Cancer and Can Be Used as Reflex Tests

Manuel M. Garrido, José C. Marta, Rui Bernardino et al. · Archives of Pathology & Laboratory Medicine · 2021 · 12 citations · Full text

Medicine, Oncology, Urology +17